|
WO2021069875A1
|
|
Composition for delivering nitric oxide to skin
|
|
GB201915768D0
|
|
Treatment of lung conditions
|
|
GB201914435D0
|
|
Composition for delivering nitric oxide to skin
|
|
GB201914437D0
|
|
Composition for delivering nitric oxide to skin
|
|
GB201616003D0
|
|
Composition for the treatment of a fungal infection
|
|
US2015030702A1
|
|
Nitric oxide-generating skin dressings
|
|
US2015086651A1
|
|
S-nitrosothiol-generating skin dressings
|
|
GB0907553D0
|
|
Treatment of human or animal body surface infection
|
|
GB0901456D0
|
|
Treatment of psoriasis
|
|
GB0821149D0
|
|
Transdermal delivery of therapeutic agents from a composite hydrated hydrogel and dry film
|
|
GB0715554D0
|
|
Improvements relating to skin dressings
|
|
GB0715556D0
|
|
Improvements relating to skin dressings
|
|
GB0715290D0
|
|
A nitric oxide generating pressure-relief pad
|
|
GB0700523D0
|
|
The Stabilisation Of Proteins
|
|
GB0626021D0
|
|
The stabilisation of proteins
|
|
GB0614278D0
|
|
Hydrogen peroxide delivery system
|
|
GB0610140D0
|
|
Protein stability
|
|
GB0610095D0
|
|
Vaccine formulation
|
|
GB0606921D0
|
|
Skin dressing
|
|
EP1767225A1
|
|
Method for stabilisation of a protein solution by addition of hydroxyl radical quenchers and its sterilisation by ionising radiation
|
